Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hodgkin's disease. Diagnostic procedures

P Carde1

  • 1Institut Gustave-Roussy, Villejuif, France.

Bailliere'S Clinical Haematology
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Minimal cancer staging may necessitate more intensive treatments due to lost information from staging laparotomy. Objective biological markers and dynamic testing are crucial for patient safety in updated staging protocols.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin's lymphoma.

Bone marrow transplantation·2016
Same author

Telomere shortening: a new prognostic factor for cardiovascular disease post-radiation exposure.

Radiation protection dosimetry·2014
Same author

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin's lymphoma patients and poor clinical outcome.

Annals of oncology : official journal of the European Society for Medical Oncology·2009
Same author

Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation.

Leukemia & lymphoma·2005
Same author

Outcome of elderly patients with aggressive Non-Hodgkin's lymphoma refractory to or relapsing after first-line CHOP or CHOP-like chemotherapy: a low probability of cure.

Leukemia & lymphoma·2004

Area of Science:

  • Oncology
  • Medical Diagnostics

Background:

  • The trend towards "minimal" cancer staging risks inadequate assessment.
  • Renouncing staging laparotomy and lymphangiogram compromises final stage accuracy.
  • This necessitates more intensive treatments like radiotherapy or chemotherapy.

Purpose of the Study:

  • To evaluate the impact of minimal staging on treatment intensity.
  • To identify alternative methods for accurate cancer staging.
  • To ensure patient safety despite changes in staging procedures.

Main Methods:

  • Analysis of information loss from renounced staging procedures.
  • Evaluation of prognostic factors and biological parameters (ESR, albumin, blood counts, soluble CD30).
  • Assessment of a dynamic approach using repeated biological, functional, and imaging tests.

Related Experiment Videos

Main Results:

  • Minimal staging protocols may lead to less secure final staging.
  • Staging laparotomy provided irreplaceable information for accurate staging.
  • Objective biological parameters and dynamic testing can compensate for lost information.

Conclusions:

  • Minimal staging requires careful consideration due to potential underestimation of disease extent.
  • Objective biological markers and dynamic monitoring are essential for safe and effective cancer management.
  • A dynamic, re-evaluative approach ensures patient safety in updated staging protocols.